Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice

1 Feb 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26829317
DOI: 10.1038/nbt.3469

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn micePMID 26829317Read ↗

The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases.Semantic proximity Read ↗

Current Status on Clinical Development of Adeno-Associated Virus-Mediated Liver-Directed Gene Therapy for Inborn Errors of MetabolismSemantic proximity Read ↗

Liver directed adeno‐associated viral vectors to treat metabolic diseaseSemantic proximity Read ↗

Gene therapy for urea cycle defects: An update from historical perspectives to future prospectsSemantic proximity Read ↗

Treatment of a metabolic liver disease by <i>in vivo</i> prime editing in miceSemantic proximity Read ↗

Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing.Semantic proximity Read ↗

Novel vectors and approaches for gene therapy in liver diseasesSemantic proximity Read ↗

CRISPR/Cas9 therapeutics for liver diseases.Semantic proximity Read ↗

Therapeutic Knock-in Genome Editing Using Single AAV Vectors in Mouse Models of Inherited Liver DiseaseSemantic proximity Read ↗

In vivo prime editing of a metabolic liver disease in miceSemantic proximity Read ↗

Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver.Semantic proximity Read ↗

Emerging and potential use of CRISPR in human liver diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.